← Back

ABTAbbott

$101.95-1.36%Real quote · delayedMedical devicesMedtech & life sciences · 10 peers →

🏛️ Company factsSEC filings + FINRA official data

Annual revenue $44.3B · latest quarter up 7.8% YoY · profitable (FY net income $6.5B) · short activity below its recent average — bears covering.

FY revenue

$44.3B

2025-12

Latest Q YoY

+7.8%

Gross margin

13.8%

FY net income

$6.5B

Diluted EPS

$3.73

Short volume

31.5%

20d avg 48.6% · shorts covering

🐋 5%+ ownership filings (last 180d)

The parties below hold over 5% of this company and disclosed it to the SEC (mandatory in US markets). "Activist" filers state an intent to influence the company; "Passive" are pure investment positions.

2026-04-29passive (13G)VANGUARD CAPITAL MANAGEMENT LLC
2026-03-26passive (13G)VANGUARD GROUP INC

🎯 Market expectations

Expectation reliability High · 79/100

Nasdaq analyst consensus · the pre-news baseline

Next quarter (Sep 2026) consensus$1.43Estimate range $1.41 ~ $1.46 · 8 analystsRevisions (4w):↑1

History: actual vs consensusavg +0.8%

Jun 2026$1.31 vs $1.28+2.34%
Mar 2026$1.15 vs $1.14+0.88%
Dec 2025$1.50 vs $1.500%
Sep 2025$1.30 vs $1.300%

The takeaway

It has tracked consensus closely — no systematic over- or under-shooting.

Analyst estimates, not our forecast · not investment advice

What's moving this stock lately

2 direct · 0 2nd-order · 0 thematic

Ranked by impact strength · strength = estimated move × freshness decay (shorter-lived effects decay faster)

#1▼1.13%DirectFDA Takes Steps to Maintain Newborn Access to Life-Saving Starter Nutrition Products8d ago
Abbott's Similac line has faced heightened import competition since the 2022 shortage, and this FDA action extends that pressure.
Impact chain →
Also named: RBGLY · PRGO · NSRGY
#2▼0.49%DirectHere are the stocks to favor in the fourth quarter — and those you should avoid2d ago
Named an avoid pick, as slowing device-segment growth tempers sentiment despite 7.8% YoY revenue growth.
Impact chain →
Also named: AAPL · AVGO · ADBE · AMZN · BAC · BK

🕰️ Price × news · engine report card

Drag to pan, scroll to zoom · real daily bars and volume

The 5 engine calls on this chart (hit / miss / pending) are Pro — price and volume only for now▂ volume

📜 Call history (newest first

🔒 Pro only

5 engine calls on this stock — each with direction, magnitude and its verified outcome · sign up to view

🔒 Pro only

Impact chains · crowding · conviction engine · insider signals — free 7-day trial on signup.